Eikon Therapeutics
eikontx.comLocations
Hayward, CA, USA · San Francisco, CA, USA · United States
industry
Health · Biotechnology · DeepTech
Size
201-1000 employees
Stage
Series B
founded in
2019
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells.
Something looks off?Open jobs at Eikon Therapeutics